✦ LIBER ✦

189: γδ T cells as immunotherapy for glioblastoma multiforme

✍ Scribed by C. Suarez; N.L. Bryant; Y. Gillespie; R.D. Lopez; J.M. Markert; L.S. Lamb

Book ID: 116279370
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 54 KB
Volume: 13
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2006.12.193

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical evaluation of ex vivo expand

Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme

✍ Nichole L. Bryant; G. Yancey Gillespie; Richard D. Lopez; James M. Markert; Gret 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 724 KB

T-cell apoptosis in human glioblastoma m

T-cell apoptosis in human glioblastoma multiforme: Implications for immunotherapy

✍ David G. Walker; Teong Chuah; Michael J. Rist; Michael P. Pender 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 577 KB

γδ T-cell immunotherapy for lung cancer

✍ Yukihiro Yoshida; Jun Nakajima; Hiromi Wada; Kazuhiro Kakimi 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 202 KB

γδ T cells: A new frontier for immunothe

γδ T cells: A new frontier for immunotherapy?

✍ Lawrence S. Lamb Jr.; Richard D. Lopez 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Peripheral γδ T-lymphocytes as an innova

Peripheral γδ T-lymphocytes as an innovative tool in immunotherapy for metastatic renal cell carcinoma

✍ Viey, Emilie ;Laplace, Catherine ;Escudier, Bernard 📂 Article 📅 2005 🏛 Expert Reviews 🌐 English ⚖ 311 KB

Adoptive immunotherapy for recurrent gli

Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2

✍ Randall E. Merchant; Angus J. Grant; Lynn H. Merchant; Harold F. Young 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

Thirteen patients with recurrent glioblastoma were treated with adoptively transferred autologous lymphokine activated killer (LAK) cells and recombinant interleukin-2 (rIL-2). Patients' blood mononuclear cells (MNC) obtained by leukapheresis were cultured at 2.5 million MNC per ml for 3 to 5 days i